The debate will take the form of short opening presentations providing background information on the current state of PSI finances and a summary of the PSI/RSS merger proposal. Following initial statements from the debaters in favour of and against the merger, questions and statements will be taken from the floor in person or from those attending online. Statements should be limited to 2 mins.
To help the meeting run smoothly, please submit a request to make a statement in advance to the following email address (email@example.com). Priority will also be given to questions submitted in advance.
PSI members will be asked to vote on a proposed merger between RSS and PSI from Friday 15th September. The voting will take place online with the results being announced at the extraordinary general meeting, Friday 28th October 2016.
More details, including the terms and answers to frequently asked questions are available at http://www.psiweb.org/rss. Please keep checking the website for updates.
PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.
Discover your potential by working as a Covance Senior Principal / Principal Biostatistician. You'll enjoy a varied role working for different sponsors across several therapeutic areas, leading projects and mentoring junior members of the department.
Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.